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Objective: To investigate the prognostic accuracy of longitudinal analysis of amplitude-
integrated electroencephalogram (aEEG) background and seizure activity to predict long-term 
neurodevelopmental outcome in hypoxic-ischemic encephalopathic (HIE) neonates receiving 
therapeutic hypothermia (TH).  
Study design: Prospective single-center cohort study of 149 neonates with moderate-to-severe 
HIE, gestational age ≥ 35 weeks at a tertiary Neonatal Intensive Care Unit. Single-channel 
aEEG background and seizure activity was monitored over 84 hours during TH and rewarming, 
then scored for every 6-hour interval.  Neurodevelopmental outcome was assessed using Bayley 
Scales of Infant Development (Second Edition). Good outcome was defined as having both 
mental development index (MDI) and psychomotor development index (PDI) scores ≥ 70 while 
poor outcome was defined as either MDI or PDI < 70 or death. Regression modelling for 
longitudinal analysis of repeatedly measured data with 5-fold cross validation was applied, and 
area under receiver operator characteristic curve (AUC) was calculated. 
Results: Ninety-three (62%) patients had good and 56 (38%) had poor outcome. Longitudinal 
aEEG background analysis combined with the information on both electrographic and clinical 
seizures had excellent predictive value (AUC: 0.90 (95% CI 0.85-0.95), better than single aEEG 
scores at any time point. The reclassification rate of this model compared to the conventional 
analysis of aEEG background at 48 hours was 19% (26 patients), of which 14% (19 patients) 
were reclassified correctly. An online outcome prediction tool was developed based on our data. 
Conclusions: Longitudinal analysis of aEEG background and seizure activity is a valuable and 




Amplitude-integrated electroencephalogram (aEEG) is a bed-side tool that allows real-
time monitoring of cerebral activity in neonates, primarily during hypoxic-ischemic 
encephalopathy (HIE). 
The three key prognostic features of aEEG monitoring are background pattern, the 
emergence of sleep-wake cycling and seizure activity during the first days of life. Several 
studies and meta-analyses concluded that a persistently abnormal background aEEG pattern at 
48 hours or beyond during hypothermia treatment1,2,3,4 or the lack of sleep-wake cycles by 96 
hours of life are strong predictors of adverse neurodevelopmental outcome. 5,6,7 Less data is 
available regarding early seizures, but seizure activity is generally related to poor outcome,8,9 
and high seizure burden was described as an independent predictor of brain injury on magnetic 
resonance imaging (MRI).10 
Although it may seem to be an attractive approach to analyze a single cross-sectional 
segment, it will not take into consideration fluctuations of generalized trends, and may lead to 
information loss in individual patients. We hypothesized that a longitudinal analysis of aEEG 
background activity during TH and the subsequent rewarming period would better reflect the 
evolution pattern of brain injury. We analyzed the aEEG and seizure activity over the first 84 
hours of life in 6-hour intervals in a large cohort of neonates diagnosed with HIE treated with 
TH. Our aim was to determine the predictive power of aEEG longitudinal analysis on long-
term neurodevelopmental outcomes and evaluate the effect of electrographic and/or clinical 





This was a prospective single-center cohort study conducted in the Neonatal Intensive 
Care Unit of the 1st Department of Pediatrics, Semmelweis University Budapest, Hungary. The 




We enrolled 213 consecutive neonates born between January 2013 and July 2018, 
diagnosed with moderate-to-severe HIE.11 Whole-body cooling was induced as described in the 
TOBY trial; initiated within the first 6 hours of life, maintained for 72-hours, followed by 
gradual rewarming.12 Exclusion criteria were gestational age of <35 weeks, postpartum 
asphyxia, congenital malformation or concurrent cerebral lesions. Patients where the cooling 
protocol or follow-up requirements were not adhered to were excluded. The CONSORT flow-
diagram of enrolment is shown in Figure 1 (online). 
 
Equipment 
Cerebral activity was recorded using continuous single channel (biparietal, P3-P4) 
aEEG monitoring (Olympic CFMTM 6000 Monitor, Olympic Medical, Natus Medical 
Incorporated, EEG-1200K Nihon Kohden Corporation). The signal was filtered to exclude 
frequencies lower than 2 Hz and higher than 20 Hz, rectified and displayed in microvolts on a 
semi-logarithmic scale at a speed of 6 cm per hour. Recording was started as soon as possible, 
but always before 6 hours of age, continued for the duration of therapeutic hypothermia and 
rewarming period for a total of 84 hours of study period.  
Scoring 
The aEEG background activity was scored for every 6-hour interval, converting the 
Hellström-Westas criteria13 to a numeric value: continuous normal voltage (CNV: score 1), 
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discontinuous normal voltage (DNV: score 2), burst suppression (BS: score 3), continuous low 
voltage (LV: score 4) and flat trace (FT: score 5).  
The frequency and duration of electrographic and clinical seizures in each interval was 
documented (0: no seizure, 1: seizure with duration less than 15 minutes, 2: repetitive seizures 
or lasting longer than 15 minutes or status epilepticus). The first appearance of sustained CNV 
or DNV (lasting over a 3-hour period) on the aEEG was defined as aEEG recovery.  
Clinical care 
All patients were mechanically ventilated during the hypothermia treatment as per our 
protocol. First line sedation was morphine sulphate infusion (loading dose of 100 µg/kg, 
followed by continuous infusion of 10 µg/kg/hour) adjusted based on response. Second line 
sedation was midazolam (boluses of 100 µg/kg or continuous infusion of 100 µg/kg/hour as 
required). Our first line anticonvulsive treatment was phenobarbital sodium (loading dose of 20 
mg/kg, maintenance dose: 5 mg/kg/day). Repetitive seizures / status were treated with either a 
second loading dose of phenobarbital or phenytoin sodium (loading dose of 20 mg/kg, 
maintenance: 4 mg/kg/day) or levetiracetam (loading dose: 30 mg/kg, maintenance dose: 20 
mg/kg 12 hourly).  
MRI was performed on 136 (91%) infants at a median age of 4.7 days at the Medical Imaging 
Center, Semmelweis University, Budapest, on a 3 Tesla Philips Achieva scanner (Philips 
Medical System, Best, The Netherlands). T1 and T2 diffusion-weighted images with apparent 
diffusion coefficient measurement were performed and were scored according to the grading 
system developed by Barkovich et al.14,15 MRI scans were classified as either no injury, mild 
injury (score of 1 in the deep nuclear grey matter or a score of 1-3 in a watershed pattern) or 
moderate-severe brain injury (score of >1 of in the deep nuclear grey matter or a score of ≥3 




Bayley Scales of Infant Development (Second Edition) score was used to assess 
neurodevelopmental outcome.16 The follow-up appointment was at 16-42 months of age 
undertaken by a trained pediatrician or psychologist blinded to the clinical history. Good 
outcome was defined as having both mental development index (MDI) and psychomotor 
development index (PDI) scores ≥ 70 while poor outcome was defined as either MDI or PDI < 
70 or death. 
 
Statistical analysis 
Descriptive statistics are presented as mean  standard deviation (SD) or median with 
interquartile ranges (IQR) for continuous variables and as percentage (%) for categorical 
variables. Student’s t test or Mann-Whitney test was used to compare continuous variables, as 
appropriate, while Fisher’s exact test was used for categorical variables. Interrater reliability of 
aEEG scoring was analyzed using intraclass correlation coefficient (ICC) in 100 randomly 
selected 6-hour periods. 
To calculate the predictive power of aEEG background activity, as a reference, we first 
analyzed the predictive power of numerical scores for each individual 6-hour period using the 
area under receiver operator characteristic curve (AUC-ROC). Next, we used seven different 
regression methods17 to handle a repeatedly measured predictor over time (aEEG background 
pattern in 6-hour intervals). Specific details of the mathematical models can be found online 
(Prediction model development). The best model, that was based on the linear regression slope-
coefficient and the mean of aEEG scores in each patient, was then validated with 5-fold cross 
validation repeated 1000 times to ensure the generalizability of our results (our dataset was 
partitioned for 5 rounds into complementary subsets, the analysis was performed on the training 
subsets and then validated on the other subset before the averaged validation results were 
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reported). We accepted p<0.05 as a level of significance. R Statistical Software, Version 4.0.3 
(R Foundation for Statistical Computing, Vienna, Austria) and GraphPad Prism, Version 9.0.2. 
(GraphPad Software, San Diego, CA, USA) were used for data analysis and plotting.  
 
RESULTS 
A total of 149 infants were included in our study after exclusions. Demographic and 
clinical characteristics of the population are shown in Table 1. Neurodevelopmental outcome 
assessment was performed at a median age of 24 months (IQR 19-35) with 93 (62%) patients 
classed as having good and 56 (38%) as poor outcome. Patients with poor outcome had a lower 
mean gestational age, birth weight, worse Apgar scores and initial blood gas values. A total of 
19 (13%) infants deceased, 10 of whom died within the 84-hour study period. 
 
aEEG background pattern 
The aEEG background pattern for each interval was assessed by two neonatologists 
blinded to the participants’ clinical history. Interrater reliability was high (ICC=0.915 (95% CI: 
0.865, 0.946, Cohen's =0.92). Median aEEG scores were analyzed in 6-hour intervals and 
improved with time in both outcome groups (Figure 2). There was a significant difference in 
the median aEEG scores calculated for 84 hours between the good and poor outcome groups 
(3.4 vs. 1.4 respectively, p<0.0001, Table 2).  
Further analysis of the aEEG background pattern in the two outcome groups is shown 
in Figure 3. CNV was observed in 22 infants (24%) at 6 hours, 58 (63%) at 48 hours and 54 
(59%) at 84 hours in the good outcome group, while in the poor outcome group, no infant had 
CNV at 6 hours, 7 (13%) at 48 hours and 6 (11%) at 84 hours.  
At 84 hours, aEEG recovery was attained in 86 (95%) patients in the good outcome 




During the 84 hours of the study period, clinical seizures were observed in 65 infants 
(44%), while electrographic seizures occurred in 68 (46%) both of which were more frequent 
in the poor outcome group (Table 2). The majority (70.5%) of the first electrographic seizures 
appeared within the first 24 hours. Electrographic and clinical seizures were detected in 44 
(29%) infants. There were 60 infants (40%) who had neither clinical nor electrographic 
seizures. The distribution of seizure activity over time is shown in Figure 4 (online).  
 
Prediction 
The predictive power of longitudinal aEEG analysis on neurodevelopmental outcome 
was evaluated using a three-step approach. First, we tested the performance of numerical aEEG 
scores for each 6-hour period in classifying infants to good and poor outcome groups using 
AUC-ROC analysis. The specificity for outcome prediction increased from 0.55 at 6 hours to 
0.94 at 84 hours, while the sensitivity decreased from 0.93 at 6 hours to 0.53 at 84 hours (Table 
3. online). There were 5 patients with abnormal aEEG background activity at 84 hours who had 
a good outcome.  
Secondly, we applied several different mathematical models17 to incorporate 
longitudinal predictor information from repeatedly measured aEEG background activity (Table 
4. online, and Prediction model development online). We used a statistically rigorous approach 
to avoid over fitting, and the best regression model yielded an AUC of 0.90 (95% CI 0.85-0.95). 
Next, we tested the effect of further covariates on outcome prediction. The presence of both 
electrographic and clinical seizures during the study period was found to slightly increase the 
predictive power (AUC: 0.91 (95% CI 0.86-0.96), sensitivity: 0.78, specificity: 0.88) (Figure 
 10 
5.). Other variables including blood gas values (pH, BE, lactate), cumulative sedative or 
anticonvulsive treatment did not significantly improve outcome prediction.  
Finally, we performed a 5-fold cross validation repeated 1000 times, to ensure 
generalizability, which yielded an AUC of 0.90 (95% CI 0.85-0.95). The reclassification rate 
of this model compared to the conventional analysis of aEEG background at 48 hours was 19% 
(26 patients), of which 14% (19 patients) were reclassified correctly (17 patients from poor to 
good outcome).  
Based on these results, we developed an online outcome prediction tool and made it 




Our results suggest that in HIE patients treated with TH longitudinal analysis of aEEG 
background and seizure activity over 84 hours in 6-hour intervals had a higher predictive value 
for neurodevelopmental outcome than analyzing the aEEG at distinct time points. When 
compared with a conventional prediction model, our results have led to correct reclassification 
in 14% of the neonates, the majority of whom were reclassified from poor to good outcome 
groups.  
 The prognostic performance of aEEG monitoring in infants with HIE has been studied 
extensively before on smaller patient populations 3-6,18 and in combination with near infrared 
spectroscopy.19, 20 As therapeutic hypothermia became standard practice in HIE, the pattern of 
changes in aEEG has been shifted in time, most likely due to the neuroprotective effects of 
cooling.6  
A large meta-analysis based on a population extracted from three small studies assessed 
the role of aEEG as a prognostic tool on long-term development. When stratified for patients 
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receiving hypothermia, they found an AUC of 0.86, 0.85 and 0.91 at 24, 48 and 72 hours, 
respectively, with a maximum predictive reliability achieved at 72 hours of life.1 These data are 
comparable to our results based on aEEG scores in respective single time periods. The most 
comprehensive meta-analysis to date included 187 patients and reported pooled sensitivity and 
specificity values to describe the predictive value of abnormal aEEG background activity in 
cooled encephalopathic neonates.2 They calculated a sensitivity of 0.95, 0.85 and 0.67, and 
specificity of 0.75, 0.93 and 0.97 at 24, 48 and 72 hours of life, respectively. Of note, in this 
analysis, only CNV background activity was considered as normal. These results are again 
similar to our findings in the pre-defined time points. Finally, a recently published review based 
on nine studies analyzed the long-term predictive power of various clinical tests in 
encephalopathic neonates.21 Their prediction of an unfavorable neurodevelopmental outcome 
using aEEG background activity during the immediate postnatal period had an AUC 0.78, 
which is considerably lower than that of the longitudinal analysis proposed by our group. 
Seizure activity in HIE infants is reported in several publications, however, there seems 
to be a lack of consistency in the categories used.  The association between seizure activity and 
short term (MRI) outcome, independent of aEEG background, was described in a study of 85 
HIE infants treated with TH.10 It was found that 52% of the patients had seizures detectable on 
aEEG, 35% of which were repetitive or status epilepticus. This was confirmed by our findings. 
Multimodal cross-sectional evaluation was used by another group, where they combined aEEG 
background pattern, seizure activity and near-infrared spectroscopy data for short-term 
outcome prediction by MRI.19 Their combined AUC of 0.80, 0.84 and 0.67 at 24, 48 and 72 
hours, respectively represents a considerably lower prognostic performance compared to our 
results. 
Clearly, there are other factors that are worth taking into account that may influence 
long-term outcome, including the level of ongoing developmental care, the presence of a 
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supportive family background and socio-economic status or possibly unreported decision-
making processes that a poor aEEG may have on redirecting the focus of care. In our cohort 
there were 5 infants with abnormal aEEG background activity at 84 hours who went on to have 
a good outcome. These findings are in line with previous publications and suggest that 
additional variables should be considered to refine the accuracy of prognosis. 
The novelty of our approach is that instead of the conventional intermittent analysis, we 
propose a continuous evaluation of aEEG background activity. Using mathematical modelling, 
we were able to harness information about the variable’s trajectory or development over time, 
providing us with more accurate predictions than just single measurements.17  
We recognized, that complex regression models are difficult to apply in everyday use 
and a simple model may be more appealing to clinicians. Therefore, we developed an open-
access, online, user-friendly outcome prediction tool that makes our results easily applicable in 
clinical practice and presents results in the form of a subject specific probability of outcome. 
As the concept of precision medicine becomes embedded in neonatology, individual risk 
assessment of neonates increasingly relies on continuous neurointensive monitoring.22,23 To the 
best of our knowledge, ours is the first online tool used for longitudinal aEEG data assessment, 
which has the potential to benefit both clinical and research purposes.  
Admittedly, there are potential limitations to our study. Firstly, sleep-wake cycling were 
not consistently recorded when our study was commenced, so we could not include this data in 
our analysis. Secondly, 31 patients unfortunately had to be excluded as their 
neurodevelopmental follow-up was not performed within the required time, although an 
analysis of their demographic parameters did not show any significant difference from those 
included in the study. The results of internal validation are reassuring, but as the aEEG 
prediction tool is now available online, we hope that prospective external validation will 
become possible. 
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We believe however, that our study also has numerous strengths. Our 149 HIE infants 
receiving TH with continuous aEEG monitoring over 84 hours is one of the largest cohort 
reported to date. While most studies focus on early MRI findings as short term clinical outcome, 
our use of the Bailey II test performed at a median of 24-month age represented functional long-
term neurodevelopmental outcome. Finally, the application of seven different mathematical 
models for longitudinal analysis of aEEG background activity is a novel approach and provided 
us with a robust process for determining the best outcome prediction method.   
We conclude that longitudinal analysis of aEEG background and seizure activity is a 
valuable and accurate prognostic tool, which may assist clinicians in their discussion with 
families, help initiate early interventions and individualized treatment plans that are necessary 
to optimize outcomes for infants diagnosed with HIE. We hope our free online aEEG 
assessment tool will provide an accessible platform for our findings to be applied in daily 
clinical practice. 
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FIGURE LEGENDS: 
Figure 1. (online) CONSORT flow-diagram of patient selection for the study. 
 
Figure 2. Median aEEG score with interquartile ranges in the good and poor outcome groups 
over time. Scores are based on the Hellström-Westas criteria. The shaded area represents aEEG 
scores considered as normal (continuous normal voltage (CNV) and discontinuous normal 
voltage (DNV)). 
 
Figure 3a. Proportion of different aEEG background patterns over time in good outcome group. 
Figure 3b. Proportion of different aEEG background patterns over time in poor outcome group. 
 
Figure 4. (online) Electrographic (single, repetitive seizures, status epilepticus) and clinical 
seizures noted during the study period in the full cohort. 
 
Figure 5. AUC-ROC analysis of aEEG score at 48 hours (red line) and longitudinally analyzed 
aEEG background scores plus electrographic and clinical seizures (blue line) for classifying 
infants to good and poor outcome groups. 
 











Gestational age (weeks) 39 (38 - 40) 40 (38 - 40) 38.5 (37 - 39.8) 0.001 
Birth weight (grams) 3300 (2890 - 3650) 
3500 (3075 - 
3710) 
3100 (2490 - 
3480) 
<0.001 
Female sex 63 (42.2) 41 (44.1) 22 (39.3) 0.61 
Delivered by Caesarean 
Section 
88 (59.5) 50 (53.8) 38 (67.8) 0.12 
Apgar 1 minute 2 (1 - 4) 3 (1 - 5) 1 (0 - 2) <0.001 
Apgar 5 minutes 5 (3 - 7) 5 (4 - 7) 3 (1 - 5) <0.001 
Maternal age (years) 33.6 (28.6 - 37.6) 34.2 (30.0 - 38.4) 31.0 (26.8 - 36.7) 0.032 
Initial blood gas values  
pH  6.98 (6.8 - 7.13) 7.01 (6.9 - 7.14) 6.85 (6.7 - 7.07) <0.001 
Base deficit (mmol/l) 17.8 (13 - 22) 16 (12.6 - 20) 19.7  (15 - 24.6) <0.001 
Lactate (mmol/l) 14.4 (11.3 - 17.5) 13.4 (10.2 - 16) 16.7 (13.7 - 19.7) <0.001 
Blood gas values at 6 hours of age  
pH  7.22 (7.08 - 7.29) 7.24 (7.16 - 7.31) 7.18 (7.0 - 7.26) 0.001 
Base deficit (mmol/l) 6.8 (3.2 -13.3) 4.8 (2.3 - 9.7) 11.0 (6.7 -15.9) <0.001 
Lactate (mmol/l) 5.3 (2.2 - 10.3) 2.9 (1.7 - 6.7) 8.3 (4.8 - 14.2) <0.001 
Cooling started (hours) 2.1 (1.4 - 3.0) 2.08 (1.4 - 2.9) 2.0 (1.3 - 3) 0.93 
Age at MRI (days) 4.7 (3.3 - 6.2) 4.8 (3.8 - 6.3) 4.3 (2.2 -5.9) 0.11 














Age at Bayley II test 
(months) 
24 (19 - 35) 24 (20 - 34.5) 23 (18.8 - 36) 0.82 
MDI 95 (84 - 104) 96 (85 - 106) 50 (50 - 63) <0.001 
PDI 95 (89 - 103) 95.5 (89 - 103) 77 (50 - 86) <0.001 
Death 19 (13) 0 (0) 19 (34) <0.001 
Values are shown as median (IQR) or count, n (%). 
Abbreviations: BE: Base Excess, MRI: magnetic resonance imaging, MDI: Mental 
development Index, PDI: Psychomotor Development Index on Bayley Scales of Infant 
Development, Second Edition (Bayley II test).  
Table
 
Table 2. aEEG features, drugs affecting aEEG patterns and seizure activity during the study 
period.  
 





Median aEEG score for 84 hours 2.0 (1.2 - 3.2) 1.4 (1.1 - 2.1) 3.4 (2.4 - 4.5) p<0.001 
aEEG normalization (hours) n=98 15 (7 - 37) 14 (5 - 32) 42 (24.5 - 55) p<0.001 
aEEG recovery at 48 hours 99 (66.4) 82 (88.2) 17 (30.4) p<0.001 
Morphine cumulative dose at 84 hours 
(micrograms) 
810 (690-920) 850 (760-990) 740 (380-740) p<0.001 
Treated with anticonvulsants  78 (52.3) 34 (36.6) 44 (78.6) p<0.001 
Received repeated loading doses or 2nd line 
anticonvulsants 
45 (30) 16 (18) 29 (50) p<0.001 
No seizure activity 60 (40.3) 47 (50.5) 13 (23.2) p=0.011 
Clinical seizures 65 (43.6) 29 (31.1) 36 (64.3) p<0.001 
Electrographic seizures 68 (45.6) 32 (34.4) 36 (64.3) p<0.001 
Electrographic seizures score (% of patient 
category) 
          0: none  
          1: single  



















Electrographic and clinical seizures 44 (29.5) 15 (16.1) 29 (51.8) p<0.001 
 
Values are shown as median (IQR) or count, n (%).  
 
  
Table 3. (online) Neurodevelopmental outcome prediction based on the appearance of CNV or 
DNV in the aEEG background activity during each 6-hour period. 
 
Time period AUC 95% CI Specificity Sensitivity NPV PPV 
0-6 hours 0.84 0.78-0.90 0.55 0.93 0.93 0.55 
6-12 hours 0.88 0.82-0.93 0.62 0.95 0.95 0.60 
12-18 hours 0.89 0.83-0.94 0.72 0.90 0.93 0.65 
18-24 hours 0.88 0.82-0.93 0.74 0.86 0.91 0.65 
24-30 hours 0.86 0.80-0.92 0.77 0.80 0.88 0.66 
30-36 hours 0.85 0.78-0.92 0.83 0.74 0.85 0.70 
36-42 hours 0.86 0.80-0.92 0.86 0.72 0.85 0.74 
42-48 hours 0.84 0.77-0.91 0.89 0.66 0.83 0.77 
48-54 hours 0.82 0.75-0.90 0.89 0.63 0.82 0.76 
54-60 hours 0.83 0.76-0.90 0.90 0.65 0.83 0.77 
60-66 hours 0.80 0.72-0.88 0.90 0.62 0.82 0.76 
66-72 hours 0.80 0.73-0.88 0.90 0.54 0.80 0.73 
72-78 hours 0.82 0.74-0.89 0.88 0.56 0.80 0.70 
78-84 hours 0.83 0.75-0.90 0.94 0.53 0.80 0.83 
 
Abbreviations: CNV: continuous normal voltage; DNV: discontinuous normal voltage; AUC: 
area under the receiver operator characteristic curve; CI: confidence interval; NPV: negative 




Table 4. (online) Comparison of methods for outcome prediction modeling using repeatedly 
measured aEEG background activity scores. (Results before cross-validation) 




all 14 aEEG scores were 








in our case the best 
aEEG score was found at 
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summarised 






calculation is based on 
the difference between 
the consecutive aEEG 
scores 




calculation is based on 
the difference between 
the measured and 
estimated aEEG scores 
using regression from 
the previous 
measurements 
0.92 0.87-0.96 0.73 0.97 
Growth curve 
method 
calculation is based on 
the mean and the slope 
coefficient of aEEG 
scores using a linear 
regression curve for each 
individual 























Neonates with moderate to severe 
HIE, treated with hypothermia, 
monitored with aEEG for 84 hours  
(n= 213) 
Inclusion criteria not met 
♦  Postnatal asphyxia (n=7) 
♦  Low gestational age < 35 weeks (n= 4) 
♦  Congenital malformation (n= 6) 
♦  Concurrent cerebral lesions on MRI (n= 9)  
Protocol exclusion 
♦  Not adhering to cooling protocol (n=7)  
 
Patients with Bayley II 
neurodevelopmental 
outcome examination 
between 16-42 months 
(n= 149) 
Lost to follow-up 
♦  Follow-up not performed in time (n=31) 
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Prediction model development 
 
Models were developed for the prediction of neurodevelopmental outcome (good/poor) 
using 14 repeatedly measured aEEG background activity scores taken at 6-hour intervals. In all 
the investigated prediction models, linear relationships between the predictor variables and the 
outcome were assumed. The models were applied to patients who survived the TH period and 
had no missing aEEG data in the 14 time intervals.  Based on the prediction methods using 
repeatedly measured data by Welten et al.1 the following seven methods were applied: 
1. All measurements method. In this method, all the 14 aEEG background readings were 
used as separate predictors in a multivariable regression analysis. 
2. Changes between subsequent measurements method. In this method, the first aEEG 
background record and all the 13 subsequent changes between readings were used to calculate 
the aEEG trajectory for each individual. Mathematically, the equation yielded identical results 
to the all measurements regression method. 
3. Conditional measurements method. In this method, the first aEEG background record 
and all the 13 subsequent conditional records were used to calculate the aEEG trajectory for 
each individual. The conditional measurement of a certain time point is obtained by taking the 
aEEG record of that specific time point and all previous records were regressed on it. Again, 
mathematically, the equation yielded identical results to the all measurements regression 
method.  
4. Best measurement method. This method used a univariable analysis in which one of 
the 14 aEEG records was used as the single “best” predictor. This method is similar to that used 
currently in clinical practice, when a single cross-sectional 6-hour aEEG interval is used to 
determine neurological outcome. This method does not take into consideration longitudinal data 
and its trajectory when providing outcome estimates. 
Appendix
5. Summary measurement (mean) method. This method used a univariable analysis in 
which the mean value of all 14 aEEG recordings was used as a single variable representing the 
predictor in the model. This method does not take into consideration data trajectory when 
providing outcome estimates. 
6. Summary measurement (maximum) method. This method used a univariable analysis 
in which the maximum value of all 14 aEEG recordings was used as the single variable 
representing the predictor in the model. Again, the method does not take into consideration data 
trajectory when providing outcome estimates. 
7. Growth curve method. This method uses information from a two-step analysis. First, 
a linear regression is performed to provide patient specific aEEG trajectories. Second, the mean 
of all measurements and the patient-specific slope coefficient are entered in a model to predict 
the neurodevelopmental outcome.  
 
The following considerations were used when choosing the final regression model. We intended 
to take advantage of longitudinal data collection and tried to avoid single, cross-sectional data 
analysis that may lead to information loss in individual patients. Therefore, the “best” and 
“summary measurements” methods were ruled out. We also aimed for a statistically 
parsimonious approach to avoid overfitting. Therefore, the “all measurements” and the 
mathematically similar other two methods were also excluded, leaving us with the “growth 
curve” method (see Supplemental Table 2).  Overall, the growth curve method seems to be the 
most flexible method capable of incorporating longitudinal predictor information without loss 
in predictive quality. 
 
Subsequently, to address the question of internal validity, we performed a 5-fold cross-
validation using the growth-curve method, and repeated it a 1000 times. We also tested if 
prediction power could be enhanced by adding further covariates, including the presence of 
both clinical and electrographic seizures, initial and subsequent blood gas values (pH, base 
excess, lactate), cumulative sedative or anticonvulsive treatment. After establishing the model 
with the best predictive quality for longitudinal aEEG data, we compared it with the regular 
approach of a single 6-hour aEEG background analysis at 48 hours of age and reported the 
reclassification rate for the newly developed method in determining neurological outcome. 
The analysis script written in R Statistical Software, Version 4.0.3 (R Foundation for Statistical 
Computing, Vienna, Austria) is available online at GitHub 
(https://github.com/suneonatalgroup/aeegpredictiontool). A user friendly, outcome prediction 
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